X-FAB Silicon Foundries (XFAB) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
30 Apr, 2026Executive summary
Q1 2026 revenue reached $205.8M (excluding IFRS 15 impact), up 2% year-over-year but down 6% sequentially; bookings rose 3% quarter-on-quarter to $169.4M, with a backlog of $308.4M.
EBIT for Q1 2026 was $2.3M, down 89% year-over-year and 77% sequentially; EBITDA was $34.2M, down 30% year-over-year and 19% sequentially, with an EBITDA margin of 17.5%.
Automotive segment remained soft, with a 10% year-over-year and 8% sequential revenue decline, but recovery is expected in H2 2026.
Industrial and medical segments showed strong growth, up 32% and 39% year-over-year, respectively.
Microsystems and wide-bandgap business saw record growth, with wide-bandgap revenue up 152% year-over-year to $15.1M.
Financial highlights
Gross profit for Q1 2026 was $30.7M, down 31% year-over-year and 26% sequentially; gross margin at 15.7%.
Net profit for Q1 2026 was $0.9M, down 92% year-over-year and 47% sequentially.
Capex for Q1 2026 was $26.0M; FY 2026 projected at approximately $100M.
Net debt increased to $291.4M, up $6.6M from Q4 2025, reflecting repayment of $26.4M in LTA prepayments.
Prototyping revenue reached $19.1M, up 19% year-over-year.
Outlook and guidance
Q2 2026 revenue is guided between $190M and $200M; EBITDA margin expected in the 17–20% range.
Cost-saving program initiated, including headcount reduction and operational expenditure cuts, with results anticipated by end of 2026.
Guidance based on USD/EUR exchange rate of 1.15 and excludes IFRS 15 impact.
Latest events from X-FAB Silicon Foundries
- Q4 revenue up 18% YoY to $222.3M; industrial and medical growth offset automotive softness.XFAB
Q4 20259 Feb 2026 - Q2 revenue fell 9% year-on-year to $205.1M; SiC weakness led to lower guidance, but Q4 rebound expected.XFAB
Q2 20242 Feb 2026 - Q3 revenue up sequentially, China automotive strong, CapEx high, full-year guidance lowered.XFAB
Q3 202418 Jan 2026 - Double-digit growth, major expansions, and $1.5B revenue and 35% margin targeted by 2030.XFAB
Investor Day 202411 Jan 2026 - Three-pillar strategy and $1.1B expansion drive growth in specialty semiconductors.XFAB
CMD 202531 Dec 2025 - Q1 revenue up 8% sequentially, EBITDA margin 24%, guidance and expansion plans reaffirmed.XFAB
Q1 202523 Dec 2025 - 2024 saw revenue and profit declines amid destocking, but recovery and margin gains are expected.XFAB
Q4 202423 Dec 2025 - Q2 revenue up to 8% year-over-year, guidance raised, and capacity expansion completed.XFAB
Q2 202516 Nov 2025 - Q3 revenue up 11% YoY to $229M, with strong medical and industrial growth; order intake fell.XFAB
Q3 20253 Nov 2025